色谱 ›› 2025, Vol. 43 ›› Issue (5): 498-507.DOI: 10.3724/SP.J.1123.2025.01025
黄雨霞1, 王海燕2, 张屹涵1, 蔺奕菲1, 乔晓强2,*(
), 胡良海1,*(
)
收稿日期:2025-01-19
出版日期:2025-05-08
发布日期:2025-05-07
通讯作者:
*Tel:(0312)5073196,E-mail:基金资助:
HUANG Yuxia1, WANG Haiyan2, ZHANG Yihan1, LIN Yifei1, QIAO Xiaoqiang2,*(
), HU Lianghai1,*(
)
Received:2025-01-19
Online:2025-05-08
Published:2025-05-07
Supported by:摘要:
外泌体是细胞分泌的细胞外囊泡的一种亚型,携带丰富的遗传物质及蛋白质等,外泌体膜表面有众多母细胞特有的标志物,已成为疾病诊断、疾病进展以及疾病治疗的重要依据。本文在Web of Science core collection(SCI-EXPENED)数据库中,检索2010-2024年间研究主题为“外泌体”与“生物标志物”或“诊断”或“液体活检”的研究型和综述类论文。文献计量分析结果显示,外泌体作为生物标志物标记疾病的研究关注度逐渐升高,中国是该研究的主要贡献国家;文献主要围绕癌症、炎症、糖尿病、神经退行性疾病和心血管疾病的标记诊断展开研究;通常使用色谱、质谱、拉曼光谱等技术分析外泌体核酸、蛋白质、代谢物等;常用的检验样本为血浆、血清、尿液、唾液、脑脊液等体液;外泌体作为肿瘤标志物的研究主要聚焦于肺癌、乳腺癌、前列腺癌等8种具有高发病率的癌症。本文聚焦于外泌体作为疾病生物标志物的研究领域,利用文献计量工具系统分析了2010-2024年间外泌体及其内容物作为生物标志物在疾病诊断领域中的应用,并对外泌体介导的疾病诊断和疾病治疗的发展前景和未来努力方向进行了分析和展望,期望为外泌体在疾病标志及应用方面的研究提供参考。
中图分类号:
黄雨霞, 王海燕, 张屹涵, 蔺奕菲, 乔晓强, 胡良海. 外泌体在生物标志物研究领域的文献计量学分析[J]. 色谱, 2025, 43(5): 498-507.
HUANG Yuxia, WANG Haiyan, ZHANG Yihan, LIN Yifei, QIAO Xiaoqiang, HU Lianghai. Bibliometric analysis of exosomes in the biomarker research field[J]. Chinese Journal of Chromatography, 2025, 43(5): 498-507.
| Country | Post volume | Percentage/ % | Average cited | Institution | Post volume | Percentage/ % | Average cited |
|---|---|---|---|---|---|---|---|
| China | 6084 | 37.3 | 32 | Shanghai Jiao Tong University | 339 | 2.0 | 37 |
| United States | 3987 | 24.5 | 57 | Nanjing Medical University | 302 | 1.8 | 44 |
| Italy | 1320 | 8.1 | 38 | Fudan University | 290 | 1.7 | 33 |
| Germany | 969 | 5.9 | 46 | Chinese Academy of Sciences | 229 | 1.4 | 38 |
| Spain | 737 | 4.5 | 46 | Harvard Medical School | 229 | 1.4 | 64 |
| Japan | 733 | 4.5 | 41 | Zhejiang University | 208 | 1.2 | 39 |
| England | 703 | 4.3 | 48 | Central South University | 207 | 1.2 | 24 |
| Korea | 627 | 3.8 | 38 | Southern Medical University | 192 | 1.2 | 36 |
| Australia | 577 | 3.5 | 57 | Shandong University | 191 | 1.1 | 39 |
| India | 565 | 3.5 | 21 | Capital Medical University | 187 | 1.1 | 29 |
表1 2010-2024年发文量排名前十的国家与机构
Table 1 Top ten countries and institutions in terms of the number of published papers from 2010 to 2024
| Country | Post volume | Percentage/ % | Average cited | Institution | Post volume | Percentage/ % | Average cited |
|---|---|---|---|---|---|---|---|
| China | 6084 | 37.3 | 32 | Shanghai Jiao Tong University | 339 | 2.0 | 37 |
| United States | 3987 | 24.5 | 57 | Nanjing Medical University | 302 | 1.8 | 44 |
| Italy | 1320 | 8.1 | 38 | Fudan University | 290 | 1.7 | 33 |
| Germany | 969 | 5.9 | 46 | Chinese Academy of Sciences | 229 | 1.4 | 38 |
| Spain | 737 | 4.5 | 46 | Harvard Medical School | 229 | 1.4 | 64 |
| Japan | 733 | 4.5 | 41 | Zhejiang University | 208 | 1.2 | 39 |
| England | 703 | 4.3 | 48 | Central South University | 207 | 1.2 | 24 |
| Korea | 627 | 3.8 | 38 | Southern Medical University | 192 | 1.2 | 36 |
| Australia | 577 | 3.5 | 57 | Shandong University | 191 | 1.1 | 39 |
| India | 565 | 3.5 | 21 | Capital Medical University | 187 | 1.1 | 29 |
| Cluster | Keywords* |
|---|---|
| #0 colorectal cancer | miR-21; signaling pathway; metabolism; mesenchymal stem cell; long non-coding RNA therapeutic target; tumor associated macrophages; macrophage polarization; phenotype; outer membrane vesicles; non-coding RNAs; tumor suppressor; fibroblasts; noncoding RNA; chemoresistance; cisplatin resistance; NF kappa-B; promote; microRNA expression; diagnostic biomarker; RNAs; autophagy; squamous cell carcinoma; poor prognosis; macrophages; prognostic biomarker; long noncoding RNAs; mesenchymal transition; tumor-microenvironment; circular RNAs; up regulation; roles; potential biomarkers; inhibition; long noncoding RNA; cancer cells; noncoding RNAs; epithelial mesenchymal transition; pathway; drug resistance; carcinoma; cell proliferation; down regulation; promotes; migration; circular RNA; gastric cancer; apoptosis; tumor microenvironment; angiogenesis; resistance; invasion; growth; hepatocellular carcinoma; progression; colorectal cancer; proliferation; metastasis |
| #1 liquid biopsy | promote tumor growth; cell derived microparticles; human saliva; smooth muscle cells; rheumatoid arthritis; pregnancy; mesenchymal stromal cells; cancer therapy; serum exosome; endothelial microparticles; horizontal transfer; multivesicular body; urinary exosome; progenitor cells; responses; cancer exosome; tissue; heart failure; tissue factor; intercellular transfer; adipose tissue; tumor growth; emerging role; size; insulin resistance; nanoparticle tracking analysis; myocardial infarction; circulating microparticles; cardiovascular disease; differentiation; pathogenesis; intercellular communication; in vivo; messenger RNAs; flow cytometry; mediated transfer; stromal cells; nanoparticles; T cells; transferrin receptor; tumor derived exosome; endothelial cells; drug delivery; membrane vesicles; delivery; dendritic cells; proteomic analysis; gene expression; inflammation; microparticles; cell derived exosome; in vitro; stem cells; mesenchymal stem cells; extracellular vesicles |
| #2 exosome | aptasensor; amplification; heterogeneity; KRAS; exosomal miRNA; chip; women; cell-free DNA; biopsy; tumor cells; mortality; target; nucleic acids; precision medicine; clinical significance; recurrence; DNA methylation; cell lung cancer system; chemotherapy; early diagnosis; mutations; bladder cancer; cancer diagnosis; marker; potential biomarker; cell free DNA; separation; free DNA; classification; management; prognosis; circulating tumor DNA; quantification; peripheral blood; circulating exosome; diagnostic biomarkers; gene; ovarian cancer; risk; survival; blood; pancreatic cancer; messenger RNA; DNA; lung cancer; circulating tumor cells; prostate cancer; breast cancer; liquid biopsy |
| #3 extracellular vesicles | progress; glioblastoma; diabetic nephropathy; head; discovery; platform; proteomics; genes; reveals; fibrosis; injury; miRNA; extracellular vesicles (EVs); receptor; exosome isolation; biology; communication; mass spectrometry; miRNAs; release; therapy; markers; mechanisms; mechanism; vesicles; activation; disease; secretion; microRNA; RNA; extracellular vesicle; circulating microRNAs; proteins; protein; serum; biomarker; plasma; biogenesis; diagnosis; identification; microRNAs; cancer; microvesicles; cells; biomarkers; expression; exosome |
| #4 Alzheimer’s disease | cognitive impairment; neuronal exosome; Tau; children; infection; dementia; blood brain barrier; multiple sclerosis; binding; dysfunction; amyloid beta; central nervous system; model; cell; small extracellular vesicles; alpha synuclein; association; Parkinson’s disease; brain; oxidative stress; cerebrospinal fluid; Alzheimer’s disease |
| #5 plasma diagnostics-interferometry | deposition; density; spectroscopy and imaging; plasma diagnostics-interferometry; temperature; plasma diagnostics; diagnostics |
表2 关键词聚类分析结果
Table 2 Keyword cluster analysis results
| Cluster | Keywords* |
|---|---|
| #0 colorectal cancer | miR-21; signaling pathway; metabolism; mesenchymal stem cell; long non-coding RNA therapeutic target; tumor associated macrophages; macrophage polarization; phenotype; outer membrane vesicles; non-coding RNAs; tumor suppressor; fibroblasts; noncoding RNA; chemoresistance; cisplatin resistance; NF kappa-B; promote; microRNA expression; diagnostic biomarker; RNAs; autophagy; squamous cell carcinoma; poor prognosis; macrophages; prognostic biomarker; long noncoding RNAs; mesenchymal transition; tumor-microenvironment; circular RNAs; up regulation; roles; potential biomarkers; inhibition; long noncoding RNA; cancer cells; noncoding RNAs; epithelial mesenchymal transition; pathway; drug resistance; carcinoma; cell proliferation; down regulation; promotes; migration; circular RNA; gastric cancer; apoptosis; tumor microenvironment; angiogenesis; resistance; invasion; growth; hepatocellular carcinoma; progression; colorectal cancer; proliferation; metastasis |
| #1 liquid biopsy | promote tumor growth; cell derived microparticles; human saliva; smooth muscle cells; rheumatoid arthritis; pregnancy; mesenchymal stromal cells; cancer therapy; serum exosome; endothelial microparticles; horizontal transfer; multivesicular body; urinary exosome; progenitor cells; responses; cancer exosome; tissue; heart failure; tissue factor; intercellular transfer; adipose tissue; tumor growth; emerging role; size; insulin resistance; nanoparticle tracking analysis; myocardial infarction; circulating microparticles; cardiovascular disease; differentiation; pathogenesis; intercellular communication; in vivo; messenger RNAs; flow cytometry; mediated transfer; stromal cells; nanoparticles; T cells; transferrin receptor; tumor derived exosome; endothelial cells; drug delivery; membrane vesicles; delivery; dendritic cells; proteomic analysis; gene expression; inflammation; microparticles; cell derived exosome; in vitro; stem cells; mesenchymal stem cells; extracellular vesicles |
| #2 exosome | aptasensor; amplification; heterogeneity; KRAS; exosomal miRNA; chip; women; cell-free DNA; biopsy; tumor cells; mortality; target; nucleic acids; precision medicine; clinical significance; recurrence; DNA methylation; cell lung cancer system; chemotherapy; early diagnosis; mutations; bladder cancer; cancer diagnosis; marker; potential biomarker; cell free DNA; separation; free DNA; classification; management; prognosis; circulating tumor DNA; quantification; peripheral blood; circulating exosome; diagnostic biomarkers; gene; ovarian cancer; risk; survival; blood; pancreatic cancer; messenger RNA; DNA; lung cancer; circulating tumor cells; prostate cancer; breast cancer; liquid biopsy |
| #3 extracellular vesicles | progress; glioblastoma; diabetic nephropathy; head; discovery; platform; proteomics; genes; reveals; fibrosis; injury; miRNA; extracellular vesicles (EVs); receptor; exosome isolation; biology; communication; mass spectrometry; miRNAs; release; therapy; markers; mechanisms; mechanism; vesicles; activation; disease; secretion; microRNA; RNA; extracellular vesicle; circulating microRNAs; proteins; protein; serum; biomarker; plasma; biogenesis; diagnosis; identification; microRNAs; cancer; microvesicles; cells; biomarkers; expression; exosome |
| #4 Alzheimer’s disease | cognitive impairment; neuronal exosome; Tau; children; infection; dementia; blood brain barrier; multiple sclerosis; binding; dysfunction; amyloid beta; central nervous system; model; cell; small extracellular vesicles; alpha synuclein; association; Parkinson’s disease; brain; oxidative stress; cerebrospinal fluid; Alzheimer’s disease |
| #5 plasma diagnostics-interferometry | deposition; density; spectroscopy and imaging; plasma diagnostics-interferometry; temperature; plasma diagnostics; diagnostics |
| Cluster | Author | Journal | DOI | Most influential paper | Citation |
|---|---|---|---|---|---|
| #1 | Valadi H | Nature Cell Biology | 10.1038/ncb1596 | Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | 2620 |
| Raposo G | Curr Opin Biotech | 10.1083/jcb.201211138. | Extracellular vesicles: exosomes, microvesicles, and friends | 1840 | |
| Skog J | Nat Cell Biol | 10.1038/ncb1800 | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | 1459 | |
| #2 | Théry C | J Extracell Vesicles | 10.1080/20013078.2018.1535750 | Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines | 2380 |
| Kalluri R | Science | 10.1126/science. aau6977. | The biology, function, and biomedical applications of exosomes | 1788 | |
| Van Niel G | Nat Rev Mol Cell Bio | 10.1038/nrm.2017.125 | Shedding light on the cell biology of extracellular vesicles | 1492 | |
| #3 | Melo S A | Nature | 10.1038/nature14581 | Glypican-1 identifies cancer exosomes and detects early pancreatic cancer | 1176 |
| Hoshino A | Nature | 10.1038/nature15756 | Tumour exosome integrins determine organotropic metastasis | 1115 |
表3 共被引参考文献网络中各聚类中最有影响力的文献
Table 3 Most influential papers in each cluster of the co-cited reference network
| Cluster | Author | Journal | DOI | Most influential paper | Citation |
|---|---|---|---|---|---|
| #1 | Valadi H | Nature Cell Biology | 10.1038/ncb1596 | Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | 2620 |
| Raposo G | Curr Opin Biotech | 10.1083/jcb.201211138. | Extracellular vesicles: exosomes, microvesicles, and friends | 1840 | |
| Skog J | Nat Cell Biol | 10.1038/ncb1800 | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | 1459 | |
| #2 | Théry C | J Extracell Vesicles | 10.1080/20013078.2018.1535750 | Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines | 2380 |
| Kalluri R | Science | 10.1126/science. aau6977. | The biology, function, and biomedical applications of exosomes | 1788 | |
| Van Niel G | Nat Rev Mol Cell Bio | 10.1038/nrm.2017.125 | Shedding light on the cell biology of extracellular vesicles | 1492 | |
| #3 | Melo S A | Nature | 10.1038/nature14581 | Glypican-1 identifies cancer exosomes and detects early pancreatic cancer | 1176 |
| Hoshino A | Nature | 10.1038/nature15756 | Tumour exosome integrins determine organotropic metastasis | 1115 |
图4 论文高频关键词的文章数量分布
Fig. 4 Number distribution of high-frequency keywords in papers a. based on analytical techniques; b. based on biomarker types; c. based on disease types; d. based on sample types.
|
| [1] | 杨元超, 肖人方, 吴洋涛, 白丽, 王兴亚, 翟景波. 聚二甲基硅氧烷微流控适配体传感器:开启生物标志物即时检验新时代[J]. 色谱, 2026, 44(5): 499-514. |
| [2] | 吴伟祥, 刁福强, 郭军飞, 古春明, 吴立红, 骆明勇. 基于血清与脑脊液脂质代谢组学的新生儿败血症生物标志物分析[J]. 色谱, 2026, 44(3): 286-295. |
| [3] | 王子瑞, 郑海娇, 贾琼. 磁性双功能材料的制备及用于血清中外泌体的捕获和磷肽富集[J]. 色谱, 2026, 44(3): 338-348. |
| [4] | 要振榆, 王玉飞, 朱晓雯, 杨红, 武佳, 张国军. 色谱-质谱技术在多发性硬化临床分析中的应用[J]. 色谱, 2026, 44(3): 226-233. |
| [5] | 张羽凡, 夏静雯, 朱佳源, 曾茂盛, 白静怡, 徐琴, 高杭. 分子印迹聚合物在急性冠脉综合征生物标志物测定传感器中的应用[J]. 色谱, 2026, 44(2): 180-190. |
| [6] | 祝冉, 蔡甘萍, 郑海娇, 贾琼. 分子印迹技术在疾病诊断和治疗领域的研究进展[J]. 色谱, 2026, 44(1): 2-16. |
| [7] | 钱柬坤, 何润茗, 方珂, 李晨龙, 鲍珊, 顾雯, 唐宋. 人体内多环芳烃及其衍生物的代谢转化研究进展[J]. 色谱, 2025, 43(6): 571-584. |
| [8] | 张伟亚, 陈品, 解伟欣, 高儇博, 张万峰, 代威, 林思源, 朱书奎. 基于全二维气相色谱-飞行时间质谱指纹图谱的原油溯源[J]. 色谱, 2025, 43(6): 688-695. |
| [9] | 邢宇航, 任香善, 李东浩, 刘璐. 基于微流控技术的外泌体分离分析及临床应用[J]. 色谱, 2025, 43(5): 455-471. |
| [10] | 王海燕, 谢沛涓, 乔晓强, 张丽媛. 基于亲和作用力的外泌体高效分离方法的经典策略和研究进展[J]. 色谱, 2025, 43(5): 413-423. |
| [11] | 郑李婷, 杨歌, 屈锋. 外泌体的核酸适配体筛选技术研究进展[J]. 色谱, 2025, 43(5): 424-433. |
| [12] | 卜彩婷, 竺雪冬, 张倩颖, 邵文亚. 外泌体在神经退行性疾病中的作用研究进展[J]. 色谱, 2025, 43(5): 487-497. |
| [13] | 苏雅婷, 钱小红, 秦伟捷. 脂质体与外泌体在药物递送和生物标志物筛选中的研究进展[J]. 色谱, 2025, 43(5): 472-486. |
| [14] | 卜爱香, 武光耀, 胡良海. 单细胞与单颗粒外泌体分离分析进展与展望[J]. 色谱, 2025, 43(5): 399-412. |
| [15] | 程显惠, 于文静, 王冬雪, 姜丽艳, 胡良海. 磷脂酰丝氨酸分子印迹聚合物对血浆外泌体的富集与蛋白质组学分析[J]. 色谱, 2025, 43(5): 539-546. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||